Skip to content

Kathleen Goin, Chief Operating Officer at Palvella Therapeutics, sold PVLA on Jul 15, 2026

Data as of Oct 16

▼ SELL$154K1,029 shares at $149.27Kathleen Goin Chief Operating OfficerPVLA Palvella Therapeutics, Inc.
Watch PVLA
Traded
Jul 15, 2026
Disclosed
Jul 17, 2026
Filed
2 days after the trade

Form 4s are due within two business days.

Official filing (SEC Form 4) ↗

The price around the disclosure

Kathleen Goin, Chief Operating Officer at Palvella Therapeutics, sold PVLA on Jul 15, 2026TRADEDDISCLOSED
PVLASimilar stocks (XLV — its sector index fund), rebased to PVLA's price on the disclosure day
PVLA since disclosure
−23.5%
after the sale
Similar stocks (XLV) since disclosure
+9.7%
XLV — its sector index fund

Change in closing price from Jul 17, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.

Our take

None of our tested rules fired on this trade.

Other trades in the same filing

  1. ▼ SELLKathleen Goin Chief Operating OfficerPVLA Palvella Therapeutics, Inc.$76.8Kdisclosed Jul 17 · filed 2 days after the trade
  2. ▼ SELLKathleen Goin Chief Operating OfficerPVLA Palvella Therapeutics, Inc.$125Kdisclosed Jul 17 · filed 2 days after the trade
  3. ▼ SELLKathleen Goin Chief Operating OfficerPVLA Palvella Therapeutics, Inc.$287Kdisclosed Jul 17 · filed 2 days after the trade

See every trade on PVLA →